Welcome to our dedicated page for Ellington Financial SEC filings (Ticker: EFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ellington Financial Inc. (NYSE: EFC) SEC filings page provides access to the company’s current and historical regulatory disclosures filed with the U.S. Securities and Exchange Commission. Ellington Financial uses Form 8-K filings to report material events such as dividend declarations on its common and preferred stock, announcements of estimated book value per common share as of specific dates, quarterly earnings results, senior unsecured notes offerings, and changes or amendments to equity distribution agreements supporting its at-the-market common stock offering program.
Through these filings, investors can review details about Ellington Financial’s investment activities and capital structure, including information on its Investment Portfolio and Longbridge segments, its issuance of senior unsecured notes due 2030, and the terms of equity distribution agreements with multiple sales agents. The filings also list the company’s securities registered under Section 12(b) of the Exchange Act, including common stock and several series of cumulative redeemable preferred stock traded on the New York Stock Exchange.
On Stock Titan, Ellington Financial filings are updated as new documents are posted to the SEC’s EDGAR system. AI-powered tools summarize key points from forms such as 8-K, and help highlight items related to dividends, estimated book value disclosures, financing arrangements, and other reported events. Users can quickly scan filings for information on Ellington Financial’s portfolio strategies, financing transactions, and board actions without reading every line of the underlying documents.
This page is a resource for reviewing Ellington Financial’s official regulatory communications, including exhibits and press releases that are incorporated by reference into its SEC reports.
Ellington Financial Inc. entered into an underwriting agreement to issue 8,775,000 shares of its common stock, with a 30‑day option for underwriters to buy up to an additional 1,316,250 shares on the same terms. The closing of the main share offering is expected on January 28, 2026, subject to customary conditions.
The shares are being offered under an effective shelf registration statement on Form S‑3. Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC are acting as representatives of the underwriters. Vinson & Elkins L.L.P. provided a legal opinion on the validity of the shares.
Ellington Financial Inc. is offering 8,775,000 shares of common stock at $13.50 per share, for gross proceeds of $118,462,500 and net proceeds estimated at about $117.2 million, or $134.9 million if underwriters fully exercise their 1,316,250‑share option.
The company plans to use most of the cash to redeem all 4,600,000 outstanding shares of its Series A preferred stock at $25.00 per share plus unpaid dividends, lowering its exposure to this floating‑rate security. Any remaining funds may support general corporate purposes, including acquiring targeted mortgage and credit assets. Management also estimates preliminary book value per common share between $13.14 and $13.18 as of December 31, 2025, including a previously announced $0.13 dividend.
Ellington Financial Inc. is offering 8,775,000 shares of common stock in a primary underwritten offering, with an option for underwriters to buy up to 1,316,250 additional shares. Based on 115,874,023 shares outstanding as of January 23, 2026, total common shares would rise to 124,649,023, or 125,965,273 if the option is fully exercised. The company plans to use the net proceeds mainly to redeem all 4,600,000 outstanding shares of its Series A preferred stock at $25.00 per share plus accrued dividends, and to deploy any remaining funds for general corporate purposes, including targeted mortgage and credit investments. Management also preliminarily estimates book value per common share at December 31, 2025 in a range of $13.14 to $13.18, which already reflects a declared $0.13 dividend.
BlackRock, Inc. filed an amended Schedule 13G reporting beneficial ownership of 16,450,177 shares of Ellington Financial Inc. common stock, representing 15.3% of the class as of 12/31/2025. BlackRock has sole power to vote 16,262,412 shares and sole power to dispose of 16,450,177 shares, with no shared voting or dispositive power.
The filing states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ellington Financial. It also notes that one underlying holder, iShares Core S&P Small-Cap ETF, has an interest in more than five percent of Ellington Financial’s outstanding common stock.
Ellington Financial Inc. disclosed that its Board of Directors has declared a monthly cash dividend of $0.13 per share on its common stock. The dividend will be paid on February 27, 2026 to common stockholders who are on record as of January 30, 2026.
The company also noted that it issued a press release on January 8, 2026 with further details, which is included as an exhibit to this report.
Ellington Financial Inc. director Lisa Mumford reported an equity award conversion. On December 31, 2025, she converted 7,657 OP LTIP Units, originally granted on December 14, 2023 under the company’s 2017 Equity Incentive Plan, into 7,657 shares of common stock at a stated price of $0 per share. After this transaction, she beneficially owned 88,773 common shares directly.
The OP LTIP Units were a separate non‑voting class of limited liability company interests in Ellington Financial Operating Partnership LLC that vested on September 12, 2024. According to the filing, the conversion of OP LTIP Units into common units and the redemption of those units for common shares did not represent or involve a disposition for value and the related conversion and redemption rights do not have expiration dates.
Ellington Financial Inc. reported that it has released an estimate of its book value per share of common stock as of November 30, 2025. This update was shared through a press release dated December 30, 2025, which is attached as an exhibit to the current report. The information is being provided under Regulation FD to ensure that all investors receive the same update at the same time.
The company furnished the press release as an exhibit rather than filing it, which means it is not automatically subject to certain liability provisions of the securities laws or incorporated into other SEC reports unless specifically referenced.
Ellington Financial Inc. updated its at-the-market common stock offering program so that shares having a maximum aggregate offering price of up to $500 million remain available for sale through designated sales agents. The company amended existing equity distribution agreements with Citizens JMP Securities, B. Riley Securities, BTIG and Armstrong Securities, and added Citadel Securities Institutional and Moelis & Company under new but substantively identical agreements.
The shares may be sold from time to time on the New York Stock Exchange or other markets in at-the-market transactions, with each agent eligible to receive up to 2.0% of gross sale proceeds. Sales will be made under the company’s automatic shelf registration statement on Form S-3 using a prospectus supplement dated December 23, 2025, and the company is not obligated to sell any shares under these agreements.
Ellington Financial Inc. may offer and sell up to $500,000,000 of common stock under an existing at-the-market equity distribution program. The total program size is $800,000,000, of which about $300,000,000 has already been sold, leaving $500,000,000 available under this prospectus supplement and the accompanying base prospectus.
The company, a mortgage-focused REIT listed on the NYSE under the symbol “EFC,” intends to use net proceeds primarily to acquire its targeted residential and commercial mortgage and related assets, consistent with its investment strategies and REIT and Investment Company Act requirements. Proceeds may also be used for working capital and general corporate purposes. Sales can be made from time to time through multiple agents in negotiated or “at the market” transactions, with the agents earning up to 2.0% of gross sales as compensation.
Ellington Financial Inc., a mortgage-focused REIT listed on the NYSE under “EFC,” has filed an automatic shelf registration statement that allows it and any selling security holders to offer, from time to time, a wide range of securities. These may include common stock, multiple series of preferred stock, stockholder rights, warrants, debt securities, depositary shares, and units combining these instruments.
The company states that, unless specified otherwise in a prospectus supplement, net proceeds from its own offerings will be used to purchase targeted residential and commercial mortgage assets and for general corporate purposes, while any proceeds from sales by selling security holders will go to those holders. Ellington Financial reports a diversified investment portfolio totaling approximately $4.8 billion as of September 30, 2025, and benefits from the broader Ellington platform, which had approximately $18.2 billion of assets under management as of that date.